What’s taking the Akari Therapeutics Plc (AKTX) stock to new heights?
Akari Therapeutics, Plc (Nasdaq: AKTX) a clinical-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases, confirmed that the U.S. Food and Drug Administration has granted Fast Track designation to nomacopan to treat patients affected with BP. AKTX stock surged adjacent to the news. At last check-in current trading, shares of […]